Literature DB >> 19601771

The changing face of HIV/AIDS in treated patients.

Josep M Llibre1, Vicenç Falco, Cristina Tural, Eugenia Negredo, Juan A Pineda, Jose Muñoz, Enrique Ortega, Sebastia Videla, Guillem Sirera, Esteban Martinez, Celia Miralles, Josean Iribarren, Maria J Galindo, Pere Domingo, Antonella d'Arminio-Monforte, Jose M Miro, Bonaventura Clotet.   

Abstract

The spectrum of complications emerging in successfully treated HIV-infected patients has dramatically changed since the advent of HAART. Typical AIDS-defining illnesses have been substituted by new comorbid conditions that threaten even those patients who maintain virologic suppression. Proper management of cardiovascular risk, and early diagnosis of AIDS-related and, particularly, non-AIDS-related malignancies (including papilomavirus-related neoplasms) must be introduced into the routine of care. Hot areas of investigation include HIV-associated neurocognitive disorders, hepatitis B and C coinfection, non-alcoholic fatty liver disease, progressive multifocal leukoencephalopathy and tuberculosis. Bone and kidney long-term toxicities and lipoatrophy remain as issues of paramount importance. The identification and early treatment of immune reconstitution disease is also of major interest, specially in those patients starting their antiretroviral treatment with severe CD4 cell depletion. The present review focuses on these twelve areas of increasing interest for physicians currently facing successfully treated HIV+ patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601771     DOI: 10.2174/157016209788680633

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  5 in total

1.  The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model.

Authors:  Xiqian Lan; Tomomi Kiyota; Richa Hanamsagar; Yunlong Huang; Scott Andrews; Hui Peng; Jialin C Zheng; Susan Swindells; George A Carlson; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-09       Impact factor: 4.147

2.  Changes in the socio-demographics, risk behaviors, clinical and immunological profile of a cohort of the Puerto Rican population living with HIV: an update of the Retrovirus Research Center (1992-2008).

Authors:  Christine Miranda; Diana M Fernandez; Raul O Ramon; Miriam Velázquez; Angel M Mayor; Robert F Hunter-Mellado
Journal:  Bol Asoc Med P R       Date:  2010 Jul-Sep

Review 3.  Non-AIDS-defining cancers.

Authors:  Ronald T Mitsuyasu
Journal:  Top Antivir Med       Date:  2014 Jun-Jul

4.  Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs.

Authors:  Francesc Homar; Virginia Lozano; Juan Martínez-Gómez; Itziar Oyagüez; Antonio Pareja; Antoni Payeras; Joaquín Serrano; Carmen Carratalá; Miguel Angel Casado
Journal:  Health Econ Rev       Date:  2012-09-03

5.  Controlling the HIV/AIDS epidemic: current status and global challenges.

Authors:  Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.